Product image of Levetiracetam Stragen (Levetiracetam) supplied by GNH India

Levetiracetam Stragen

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Stragen (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Stragen, is an anticonvulsant presented as an intravenous solution for intravenous use. It is employed to manage various seizure types in patients with epilepsy, working by modulating neuronal activity to reduce seizure frequency and severity across different seizure classifications.

GNH India supplies Levetiracetam Stragen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company ensures quality manufacturing, regulatory compliance, and reliable distribution to healthcare facilities across global markets.

Manufacturer / TM Owner

Stragen Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levetiracetam is an anticonvulsant indicated for several seizure disorders.

  • Partial‑onset seizures: reduces frequency of focal seizures in patients with epilepsy.
  • Generalized tonic‑clonic seizures: helps control convulsive episodes in generalized epilepsy.
  • Myoclonic seizures: decreases rapid, involuntary muscle jerks associated with myoclonic epilepsy.

How It Works

  • Levetiracetam binds to the synaptic vesicle protein SV2A, a key regulator of neurotransmitter release. This interaction modulates calcium‑dependent exocytosis, stabilizing neuronal membranes and diminishing hyper‑excitability. By reducing the release of excitatory neurotransmitters, the drug lowers the likelihood of synchronized neuronal firing that underlies seizure activity, contributing to overall seizure control.

Side Effects

Levetiracetam may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Fatigue: feeling of tiredness or lack of energy.
  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Somnolence: increased sleepiness during the day.
  • Headache: mild to moderate cranial pain.
  • Irritability: heightened emotional responsiveness.
  • Depression: low mood or loss of interest.

Serious or Rare Side Effects

  • Severe allergic reactions: rash, swelling, or anaphylaxis.
  • Stevens‑Johnson syndrome: rare but serious skin disorder.
  • Suicidal thoughts: emergence of depressive ideation or self‑harm urges.
  • Severe skin rash: extensive erythema or blistering.
  • Blood disorders: neutropenia or thrombocytopenia.
  • Multi‑organ hypersensitivity: systemic inflammatory response affecting multiple organs.

Precautions & Warnings

When prescribing Levetiracetam Stragen, consider the following precautions.

  • Renal impairment: dose adjustment may be required in patients with reduced kidney function.
  • Hepatic impairment: monitor liver function tests during therapy.
  • Pregnancy: use only if potential benefit justifies potential risk (Category C).
  • Mood changes: observe for signs of depression, irritability, or suicidal thoughts.
  • Concomitant antiepileptic drugs: assess for additive central nervous system effects.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Levetiracetam can interact with other medicines; awareness of the interaction level is essential.

Major Interactions (Avoid)

  • Carbamazepine: enzyme induction that lowers levetiracetam plasma concentrations.
  • Phenobarbital: induces metabolism, reducing levetiracetam exposure.
  • Phenytoin: similar induction effect leading to decreased levetiracetam levels.

Moderate Interactions (Monitor Closely)

  • Valproic acid: may increase levetiracetam plasma concentrations.
  • Other antiepileptic drugs: additive central nervous system depression may require dose titration.
  • Oral contraceptives: levetiracetam may reduce hormonal efficacy, consider alternative contraception.

Frequently Asked Questions

Levetiracetam Stragen is indicated for the treatment of partial‑onset seizures, generalized tonic‑clonic seizures, and myoclonic seizures in patients diagnosed with epilepsy. It helps to reduce the frequency and severity of these seizure types by stabilizing neuronal activity.

Levetiracetam binds to the synaptic vesicle protein SV2A, which plays a crucial role in neurotransmitter release. This binding modulates calcium‑dependent exocytosis, decreasing the release of excitatory neurotransmitters and thereby reducing neuronal hyper‑excitability that can trigger seizures.

The prescribed dose of Levetiracetam Stragen is individualized by the treating clinician based on factors such as the patient’s age, weight, renal function, seizure type, and response to therapy. No fixed dosing regimen is provided here; the prescriber sets the appropriate regimen.

Levetiracetam is classified as Pregnancy Category C, indicating that risk to the fetus cannot be ruled out and the drug should be used only if the potential benefit justifies the potential risk. Limited data are available for breastfeeding, so clinicians should weigh benefits against possible exposure to the infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. The team then replies with pricing, availability, shipping details (including cold‑chain handling if needed), and any required import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancers such as valproic acid. It generally has fewer drug‑enzyme interactions, a relatively favorable side‑effect profile, and can be used as adjunctive therapy, making it a versatile option in many seizure regimens.

Levetiracetam Stragen should be stored at 2‑8 °C (refrigerated). Keep the solution in its original container, protect it from light, and avoid freezing or shaking the vial to maintain product integrity.

Levetiracetam Stragen is supplied as an intravenous solution and is administered by slow infusion into a vein under the supervision of a healthcare professional. The infusion rate and duration are determined by the prescribing physician based on the patient’s clinical condition.

Serious risks include severe allergic reactions such as anaphylaxis, skin conditions like Stevens‑Johnson syndrome, and neuropsychiatric events including depression, irritability, or suicidal thoughts. Patients should be monitored closely for any of these signs, and treatment should be discontinued if they occur.

Levetiracetam Stragen is contraindicated in patients with known hypersensitivity to levetiracetam or any component of the formulation. Caution is also advised for individuals with severe renal impairment where dose adjustment may not be feasible, and for pregnant women unless the potential benefit outweighs the risk.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT